BHMP
PTLA

Bardin Hill Management Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bardin Hill Management Partners’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-982,285
Closed -$17.7M – 44
2020
Q2 		$17.7M Buy
+982,285
New +$13.7M 6.47% 8

Bardin Hill Management Partners's PTLA Position: Q3 2020 in Review

Bardin Hill Management Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 982,285 shares — an estimated $17.7M sold.

Bardin Hill Management Partners first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $17.7M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Bardin Hill Management Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Bardin Hill Management Partners sold 982,285 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $17.7M.
  • Bardin Hill Management Partners first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Bardin Hill Management Partners's Portola Pharmaceuticals, Inc. position peaked at $17.7M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Bardin Hill Management Partners's 13F filing for Q3 2020, filed 16 Nov 2020.